Esomeprazole Strontium
Product Images NDC 53746-955

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Esomeprazole Strontium (NDC 53746-955). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Esomeprazole Strontium Delayed Release Capsules 1)

Chemical structure diagram of the active ingredient esomeprazole strontium, showing its molecular composition including the strontium ion (Sr2+) and water molecules (4H2O).*

FDA Label Image

Figure2 (Esomeprazole Strontium Delayed Release Capsules 2)

A line graph showing percent maintained over six months for groups including Esomeprazole Magnesium at doses of 44.6 mg, 22.3 mg, 11.15 mg, and a placebo group. The y-axis represents percent maintained, while the x-axis shows time in months. Data points indicate the comparative effectiveness of these doses and placebo over time.*

FDA Label Image

Figure3 (Esomeprazole Strontium Delayed Release Capsules 3)

A line graph depicting percent maintained over six months for groups receiving Esomeprazole Magnesium at 44.6 mg, 22.3 mg, 11.15 mg, and placebo. It compares the maintenance percentages of these groups over time, showing differences in response between doses and placebo.*

FDA Label Image

Figure4 (Esomeprazole Strontium Delayed Release Capsules 4)

A line graph showing the percentage of patients symptom-free over 28 days. It compares three groups: Esomeprazole Magnesium 44.6 mg, Esomeprazole Magnesium 22.3 mg, and placebo. The y-axis shows percent of patients symptom-free, and the x-axis shows diary days from 0 to 28.*

FDA Label Image

Figure5 (Esomeprazole Strontium Delayed Release Capsules 5)

A line graph titled 'Percent of Patients Symptom-Free of Heartburn by Day' showing three lines representing Esomeprazole Magnesium 44.6 mg, Esomeprazole Magnesium 22.3 mg, and Placebo. The x-axis is labeled 'Diary Day' covering up to 28 days, and the y-axis shows the percent of patients symptom-free, ranging from 0 to 100%. The graph illustrates the trend of increasing symptom-free patients over time for each group.*

FDA Label Image

24.65 mg Brand Label (Esomeprazole Strontium Delayed Release Capsules 6)

Label for Esomeprazole strontium delayed-release capsules, 24.65 mg strength, in a package of 30 capsules. The label states it is Rx only and advises dispensing with a medication guide. Manufactured by Amneal Pharmaceuticals of New York LLC, with licensing from Hanmi Pharm. Co. Ltd., Seoul, Korea. The label includes storage instructions, usage cautions, and a barcode.*

FDA Label Image

49.3 mg Brand Label (Esomeprazole Strontium Delayed Release Capsules 7)

Label for Esomeprazole strontium delayed-release capsules, 49.3 mg strength. The label specifies 30 capsules per container. It includes storage instructions, dispensing info, and manufacturer details: licensed from Hanmi Pharm. Co. Ltd., Seoul, Korea, and distributed by Amneal Pharmaceuticals of New York LLC, Glasgow, KY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.